Home > Publications database > Stereoselective Reduction of Prochiral Cyclic 1,3-Diketones Using Different Biocatalysts > print |
001 | 867642 | ||
005 | 20210130003826.0 | ||
024 | 7 | _ | |a 10.1007/s10562-019-03015-y |2 doi |
024 | 7 | _ | |a 1011-372X |2 ISSN |
024 | 7 | _ | |a 1572-879X |2 ISSN |
024 | 7 | _ | |a 2128/24950 |2 Handle |
024 | 7 | _ | |a WOS:000495029200001 |2 WOS |
037 | _ | _ | |a FZJ-2019-06263 |
082 | _ | _ | |a 660 |
100 | 1 | _ | |a Contente, Martina Letizia |0 P:(DE-HGF)0 |b 0 |
245 | _ | _ | |a Stereoselective Reduction of Prochiral Cyclic 1,3-Diketones Using Different Biocatalysts |
260 | _ | _ | |a Dordrecht [u.a.] |c 2020 |b Springer Science + Business Media B.V |
336 | 7 | _ | |a article |2 DRIVER |
336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1591712552_25233 |2 PUB:(DE-HGF) |
336 | 7 | _ | |a ARTICLE |2 BibTeX |
336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
520 | _ | _ | |a We have developed biocatalytic methods for the stereoselective reduction of cyclic prochiral 1,3-diketones for the production of optically active β-hydroxyketones and/or 1,3-diols. The recombinant ketoreductase KRED1-Pglu (formulated as purified catalyst) and whole cells of wild type Escherichia coli DE3 Star were used as biocatalysts, displaying different and sometimes complementary stereoselectivity, thus allowing the preparation of stereochemically pure β-hydroxyketones (12–66% isolated yields, > 99% e.e.) and 1,3-diols (40–60% isolated yields, > 99% e.e.). |
536 | _ | _ | |a 581 - Biotechnology (POF3-581) |0 G:(DE-HGF)POF3-581 |c POF3-581 |f POF III |x 0 |
588 | _ | _ | |a Dataset connected to CrossRef |
700 | 1 | _ | |a Dall’Oglio, Federica |0 P:(DE-HGF)0 |b 1 |
700 | 1 | _ | |a Annunziata, Francesca |0 P:(DE-HGF)0 |b 2 |
700 | 1 | _ | |a Molinari, Francesco |0 P:(DE-HGF)0 |b 3 |
700 | 1 | _ | |a Rabuffetti, Marco |0 P:(DE-HGF)0 |b 4 |
700 | 1 | _ | |a Romano, Diego |0 P:(DE-HGF)0 |b 5 |
700 | 1 | _ | |a Tamborini, Lucia |0 P:(DE-HGF)0 |b 6 |
700 | 1 | _ | |a Rother, Dörte |0 P:(DE-Juel1)144643 |b 7 |u fzj |
700 | 1 | _ | |a Pinto, Andrea |0 P:(DE-HGF)0 |b 8 |e Corresponding author |
773 | _ | _ | |a 10.1007/s10562-019-03015-y |0 PERI:(DE-600)1501518-x |p 1176-1185 |t Catalysis letters |v 150 |y 2020 |x 1572-879X |
856 | 4 | _ | |u https://juser.fz-juelich.de/record/867642/files/Contente2020_Article_StereoselectiveReductionOfProc-1.pdf |y Restricted |
856 | 4 | _ | |u https://juser.fz-juelich.de/record/867642/files/Contente%20et%20al%20manuscript%20catalysis%20letters_revised_clean%20copy.pdf |y Published on 2019-11-07. Available in OpenAccess from 2020-11-07. |z StatID:(DE-HGF)0510 |
856 | 4 | _ | |u https://juser.fz-juelich.de/record/867642/files/Contente2020_Article_StereoselectiveReductionOfProc-1.pdf?subformat=pdfa |x pdfa |y Restricted |
909 | C | O | |o oai:juser.fz-juelich.de:867642 |p openaire |p open_access |p VDB |p driver |p dnbdelivery |
910 | 1 | _ | |a Forschungszentrum Jülich |0 I:(DE-588b)5008462-8 |k FZJ |b 7 |6 P:(DE-Juel1)144643 |
913 | 1 | _ | |a DE-HGF |b Key Technologies |l Key Technologies for the Bioeconomy |1 G:(DE-HGF)POF3-580 |0 G:(DE-HGF)POF3-581 |2 G:(DE-HGF)POF3-500 |v Biotechnology |x 0 |4 G:(DE-HGF)POF |3 G:(DE-HGF)POF3 |
914 | 1 | _ | |y 2020 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1160 |2 StatID |b Current Contents - Engineering, Computing and Technology |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0600 |2 StatID |b Ebsco Academic Search |
915 | _ | _ | |a Embargoed OpenAccess |0 StatID:(DE-HGF)0530 |2 StatID |
915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b CATAL LETT : 2017 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |
915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0110 |2 StatID |b Science Citation Index |
915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0111 |2 StatID |b Science Citation Index Expanded |
915 | _ | _ | |a IF < 5 |0 StatID:(DE-HGF)9900 |2 StatID |
915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b ASC |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1150 |2 StatID |b Current Contents - Physical, Chemical and Earth Sciences |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |
915 | _ | _ | |a Nationallizenz |0 StatID:(DE-HGF)0420 |2 StatID |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |
920 | 1 | _ | |0 I:(DE-Juel1)IBG-1-20101118 |k IBG-1 |l Biotechnologie |x 0 |
980 | _ | _ | |a journal |
980 | _ | _ | |a VDB |
980 | _ | _ | |a I:(DE-Juel1)IBG-1-20101118 |
980 | _ | _ | |a UNRESTRICTED |
980 | 1 | _ | |a FullTexts |
Library | Collection | CLSMajor | CLSMinor | Language | Author |
---|